Cover Image
市場調查報告書

葡萄糖耐受不良相關的全球臨床實驗檢討

Glucose Intolerance Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 217229
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
葡萄糖耐受不良相關的全球臨床實驗檢討 Glucose Intolerance Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月30日 內容資訊: 英文 78 Pages
簡介

葡萄糖耐受不良是糖尿病前兆,可以說是血糖值超過正常值但尚未診斷為糖尿病的病症。這跟胰島素抗性有關,提升心血管疾病的風險。20歲∼79歲的葡萄糖耐受不良(IGT)全球為3億4,400萬人,佔人口的7.9%,預測到2030年將增加到4億7,200萬人,增加8.4%。

本報告提供全球2011年下半年的葡萄糖耐受不良相關臨床實驗資料調查,就各地區,各階段加以分析,提供正在開發的藥物概要,介紹1982年到2011年9月目前70種登記的藥物,為您概述為以下內容。

目錄

簡介

各地區臨床實驗

  • 各國家臨床實驗
    • 亞太地區
    • 歐洲
    • 北美
    • 中東·非洲
    • 中南美
  • 金磚四國
  • G7各國
  • 各臨床實驗狀況G7臨床實驗
  • E7各國
  • 各臨床實驗狀況E7臨床實驗
  • 各階段臨床實驗
  • 未完成臨床實驗
  • 一定期間內募集的實驗對象
  • 主要的臨床試驗贊助者
    • 參與葡萄糖耐受不良臨床實驗計劃的主要企業
  • 藥物比較
  • 臨床實驗簡介
    • 主要企業
      • Merck & Co., Inc
      • Novartis
      • 鹽野義製藥
    • 大學·機關·醫院
      • Yale University
      • Seattle Institute for Biomedical and Clinical Research
      • Hadassah Medical Organization
      • University of Oslo
      • The National Institute of Diavetes and Digestive Kidney Disease
      • University of Leipzig
      • University of Sherbrooke
      • 東京大學
      • Northwestern University
      • Hillel Yaffe Medical Center
      • University of California, Los Angeles
      • Gentofte University Hospital
      • University of Copenhagen
      • Tel-Aviv Sourasky Medical Center
      • University Hospital Tubingen
      • University of Missouri
      • Emory University
      • University of Oxford
      • University of Miami
      • Lawson Health Research Institute

5個主要的臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2115CTIDB

GlobalData's clinical trial report, "Glucose Intolerance Global Clinical Trials Review, H1, 2014" provides data on the Glucose Intolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucose Intolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Glucose Intolerance
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Glucose Intolerance
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Glucose Intolerance Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Genfit SA
      • Clinical Trial Overview of Genfit SA
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • N-Gene Research Laboratories, Inc.
      • Clinical Trial Overview of N-Gene Research Laboratories, Inc.
      • Laboratoires Stella SA
      • Clinical Trial Overview of Laboratoires Stella SA
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
    • Clinical Trial Overview of Top Institutes / Government
      • Yale University
      • Clinical Trial Overview of Yale University
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
      • University of Oslo
      • Clinical Trial Overview of University of Oslo
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Universite de Sherbrooke
      • Clinical Trial Overview of Universite de Sherbrooke
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • University of Tasmania
      • Clinical Trial Overview of University of Tasmania
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Region, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Glucose Intolerance Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by N-Gene Research Laboratories, Inc., 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Stella SA, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oslo, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite de Sherbrooke, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*

List of Figures

  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top